In episode 83 of Molecule to Market, David Enloe, President and CEO at Societal™ CDMO, sat down with host, Raman Sehgal, to discuss the pharmaceutical and biotechnology supply chain, covering:
- Being at the birth of viral vectors and the-infant gene therapy field in the 90s… but choosing not to be there today.
- After a career spent all over the world – he shares his pearls of wisdom of what he’s learnt from a lifetime of international business.
- Navigating business confusion and redefining companies from the inside out, while focusing on people and patients.
- Being a humble, humane, empathetic leader that does not take himself too seriously… and makes decisions quickly.
- Uncertainty around the capital markets and what this means to the CDMO space in terms of potential headwinds